Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Anna Wagner, MD, University of Lausanne
Videos
08/11/2023
At the 2023 World Congress on Gastrointestinal Cancers, Anna Wagner, MD, discusses the addition of trastuzumab to perioperative chemotherapy for patients with HER2-positive gastric or gastroesophageal junction cancer.
At the 2023 World Congress on Gastrointestinal Cancers, Anna Wagner, MD, discusses the addition of trastuzumab to perioperative chemotherapy for patients with HER2-positive gastric or gastroesophageal junction cancer.
At the 2023 World Congress on...
08/11/2023
Oncology
John Strickler, MD, Duke Cancer Center
Videos
07/14/2023
At the 2023 World Congress on Gastrointestinal Cancers, John Strickler, MD, reviews the currently available and upcoming strategies in targeting KRAS in gastrointestinal cancers.
At the 2023 World Congress on Gastrointestinal Cancers, John Strickler, MD, reviews the currently available and upcoming strategies in targeting KRAS in gastrointestinal cancers.
At the 2023 World Congress on...
07/14/2023
Oncology
Van Morris, MD, MD Anderson Cancer Center
Videos
07/13/2023
At the 2023 World Congress on Gastrointestinal Cancers, Van Morris, MD, presented results from a phase 2 study evaluating the addition of ipilimumab to nivolumab for patients with previously treated, unresectable or metastatic squamous cell...
At the 2023 World Congress on Gastrointestinal Cancers, Van Morris, MD, presented results from a phase 2 study evaluating the addition of ipilimumab to nivolumab for patients with previously treated, unresectable or metastatic squamous cell...
At the 2023 World Congress on...
07/13/2023
Oncology
Lucjan Wyrwicz, MD, Maria Sklodowska Curie National Cancer Research Institute
Videos
07/12/2023
At the 2023 World Congress on Gastrointestinal Cancers, Lucjan Wyrwicz discusses the extended benefit of pembrolizumab plus chemotherapy when evaluating outcomes on next-line therapy for advanced HER2-negative, gastric/gastroesophageal...
At the 2023 World Congress on Gastrointestinal Cancers, Lucjan Wyrwicz discusses the extended benefit of pembrolizumab plus chemotherapy when evaluating outcomes on next-line therapy for advanced HER2-negative, gastric/gastroesophageal...
At the 2023 World Congress on...
07/12/2023
Oncology
Anup Kasi, MD, University of Kansas Cancer Center
Videos
04/20/2023
Anup Kasi, MD, discusses the debate on neoadjuvant vs adjuvant immunotherapy for patients with locally advanced HER2-positive upper gastrointestinal tract cancers, held at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Anup Kasi, MD, discusses the debate on neoadjuvant vs adjuvant immunotherapy for patients with locally advanced HER2-positive upper gastrointestinal tract cancers, held at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Anup Kasi, MD, discusses the...
04/20/2023
Oncology
Arvind Dasari, MD, MD Anderson Cancer Center
Videos
04/13/2023
Arvind Dasari, MD, discusses the important points clinicians should consider when treating patients with neuroendocrine tumors.
Arvind Dasari, MD, discusses the important points clinicians should consider when treating patients with neuroendocrine tumors.
Arvind Dasari, MD, discusses the...
04/13/2023
Oncology
Arvind Dasari, MD, MD Anderson Cancer Center
Videos
04/13/2023
Arvind Dasari, MD, reviews the new and upcoming treatment options for patients with neuroendocrine tumors at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Arvind Dasari, MD, reviews the new and upcoming treatment options for patients with neuroendocrine tumors at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Arvind Dasari, MD, reviews the...
04/13/2023
Oncology
Sonia Kupfer, MD, University of Chicago
Videos
04/01/2023
At the 2023 Great Debates & Updates in Gastrointestinal Malignancies in Chicago, regional co-chair Sonia Kupfer, MD, discussed the significant part that genetics play when treating patients with gastrointestinal cancers.
At the 2023 Great Debates & Updates in Gastrointestinal Malignancies in Chicago, regional co-chair Sonia Kupfer, MD, discussed the significant part that genetics play when treating patients with gastrointestinal cancers.
At the 2023 Great Debates &...
04/01/2023
Oncology
Gary Deng, MD, Memorial Sloan Kettering Cancer Center
Videos
04/01/2023
At the 2023 Great Debates and Updates in Gastrointestinal Cancers meeting in Chicago, Gary Deng, MD, PhD, highlighted the pillars of cancer wellness and explained how to incorporate integrative medicine into the management of patients with...
At the 2023 Great Debates and Updates in Gastrointestinal Cancers meeting in Chicago, Gary Deng, MD, PhD, highlighted the pillars of cancer wellness and explained how to incorporate integrative medicine into the management of patients with...
At the 2023 Great Debates and...
04/01/2023
Oncology
Suneel Kamath, MD, Cleveland Clinic
Videos
03/31/2023
Suneel Kamath, MD, gives an overview of his talk on circulating tumor DNA from the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting in Chicago, IL.
Suneel Kamath, MD, gives an overview of his talk on circulating tumor DNA from the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting in Chicago, IL.
Suneel Kamath, MD, gives an...
03/31/2023
Oncology

Advertisement

Advertisement

Advertisement

Advertisement